Prospective randomized comparison of the transobturator mid-urethral sling with the single-incision sling among women with stress urinary incontinence: 1-year follow-up study
Language English Country England, Great Britain Media print-electronic
Document type Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
26630947
DOI
10.1007/s00192-015-2895-2
PII: 10.1007/s00192-015-2895-2
Knihovny.cz E-resources
- Keywords
- Efficacy, Mid-urethral sling, Patient-reported outcomes, Randomized controlled trial, Single-incision sling, Stress urinary incontinence,
- MeSH
- Operative Time MeSH
- Patient Reported Outcome Measures MeSH
- Blood Loss, Surgical MeSH
- Quality of Life MeSH
- Middle Aged MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Pain, Postoperative etiology MeSH
- Prospective Studies MeSH
- Aged MeSH
- Urinary Incontinence, Stress surgery MeSH
- Suburethral Slings * adverse effects MeSH
- Groin MeSH
- Urinary Incontinence, Urge etiology MeSH
- Urologic Surgical Procedures adverse effects methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Randomized Controlled Trial MeSH
- Comparative Study MeSH
INTRODUCTION AND HYPOTHESIS: The objective was to compare the efficacy and safety of an innovative single-incision sling (SIS) with the inside-out transobturator sling (TOT) in the treatment of female stress urinary incontinence (SUI). METHODS: A prospective randomized trial was performed in a tertiary referral urogynecology center from January 2012 to December 2013. The study included women with pure urodynamic SUI. Patients were randomized to either the SIS or the TOT anti-incontinence procedure. Surgery duration, blood loss, and groin pain scores were recorded for each patient. The 1-year follow-up visit included objective and subjective cure parameters, postoperative de novo urgency, complications, and the impact on the patient's life quality. RESULTS: Of 285 patients assessed for eligibility, a total of 93 patients (32.6 %) were randomized into TOT (n = 48) and SIS groups (n = 45). There were no significant differences in either operating time or blood loss. A statistically significant difference between the two groups was found in pain scores three (5.6 ± 1.8 vs 3.1 ± 2.1, p < 0.001) and 12 h postoperatively (3.8 ± 1.7 vs 2.1 ± 1.7, p < 0.001). After 1 year, there were no significant differences between the TOT and SIS groups in objective cure rates (87.0 % vs 90.9 %; p = 0.399) or patient-reported success rates (91.3 % vs 93.2 %; p = 0.999). Incidence of postoperative de novo urgency did not differ between TOT and SIS patients. Both groups registered a significant improvement in quality of life. CONCLUSIONS: The Ophira SIS procedure has 1-year success rates comparable to standard TOT with significantly less groin pain in the early postoperative period. Both methods were safe and effective in terms of postoperative urgency and life quality improvement.
See more in PubMed
Urology. 2013 Sep;82(3):552-9 PubMed
Int Urogynecol J. 2012 Oct;23(10):1403-12 PubMed
Low Urin Tract Symptoms. 2014 Sep;6(3):172-4 PubMed
Cochrane Database Syst Rev. 2014 Jun 01;(6):CD008709 PubMed
Obstet Gynecol. 2014 Mar;123(3):553-61 PubMed
Int Urogynecol J. 2012 Sep;23(9):1285-91 PubMed
Obstet Gynecol. 2015 Jan;125(1):27-34 PubMed
Cochrane Database Syst Rev. 2015 Jul 01;(7):CD006375 PubMed
Int Urogynecol J. 2014 May;25(5):637-43 PubMed
Acta Obstet Gynecol Scand Suppl. 1990;153:7-31 PubMed
Int Urogynecol J. 2011 Jan;22(1):3-15 PubMed
Am J Obstet Gynecol. 2015 Jul;213(1):35.e1-9 PubMed
Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:91-7 PubMed
Urology. 2003 Oct;62(4 Suppl 1):16-23 PubMed
Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):563-6 PubMed
Neurourol Urodyn. 2011 Mar;30(3):284-91 PubMed
Neurourol Urodyn. 2007;26(4):492-494 PubMed
Int Urogynecol J Pelvic Floor Dysfunct. 2005 May-Jun;16(3):176-81; discussion 181 PubMed
BJU Int. 2011 May;107(10):1612-7 PubMed
